Fintel on MSN20h
Redburn Atlantic Upgrades DexCom (DXCM)
Fintel reports that on February 3, 2025, Redburn Atlantic upgraded their outlook for DexCom (NasdaqGS:DXCM) from Neutral to ...
10 growth stocks in the S&P 500's bargain -2-
Let's sort the S&P 500 healthcare sector again to show the 10 stocks with the highest percentages of "buy" or equivalent ratings. Only five companies are on both this list and the above growth list: ...
American Diversifield Holdings Corporation (ADHC) Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program
In the Spring 2024 semester, Glucoguard was invited to participate in the MADO program through our ongoing relationship with ...
10 growth stocks in the S&P 500's bargain sector
The S&P 500 index trades at a forward price/earnings ratio of 21.9. The U.S. large-cap benchmark stock index is weighted by market capitalization. The index's current forward P/E valuation is 18% ...
Here’s Why Aristotle Atlantic Focus Growth Strategy Sold its Stake in DexCom (DXCM)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The U.S. equity market ...
IDEXX targets 6%-9% organic revenue growth in 2025 with innovative product launches
IDEXX outlined its 2025 revenue target of $4.055 billion to $4.170 billion, reflecting organic growth of 6% to 9%. The CAG Diagnostic recurring revenue is expected to grow between 5% and 8% ...